203 related articles for article (PubMed ID: 36398362)
1. Pharmacotherapy for stroke prevention in nonvalvular atrial fibrillation: current strategies and future directions.
Gómez-Outes A; Suárez-Gea ML; Pérez-Cabeza AI; García-Pinilla JM
Expert Opin Pharmacother; 2022 Dec; 23(17):1941-1955. PubMed ID: 36398362
[TBL] [Abstract][Full Text] [Related]
2. Development of new anticoagulant in 2023: Prime time for anti-factor XI and XIa inhibitors.
Bentounes NK; Melicine S; Martin AC; Smadja DM; Gendron N
J Med Vasc; 2023 Apr; 48(2):69-80. PubMed ID: 37422330
[TBL] [Abstract][Full Text] [Related]
3. Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.
Kalabalik J; Rattinger GB; Sullivan J; Slugocki M; Carbone A; Rivkin A
Drugs; 2015 Jun; 75(9):979-98. PubMed ID: 25998374
[TBL] [Abstract][Full Text] [Related]
4. Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation.
Damani RH; Suarez JI
South Med J; 2016 Nov; 109(11):721-729. PubMed ID: 27812719
[TBL] [Abstract][Full Text] [Related]
5. Ischaemic stroke in a patient with non-valvular atrial fibrillation (NVAF) despite non-vitamin K oral anticoagulant (NOAC) therapy.
Zhen S; Chu F; Kodesh A; Kim J
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38199668
[TBL] [Abstract][Full Text] [Related]
6. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation and stroke: from scientific evidence to practice.
Deplanque D; Leys D
Clin Exp Hypertens; 2006; 28(3-4):251-7. PubMed ID: 16833031
[TBL] [Abstract][Full Text] [Related]
8. Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke.
Min J; Farooq MU
Postgrad Med; 2016 Aug; 128(6):620-8. PubMed ID: 27263867
[TBL] [Abstract][Full Text] [Related]
9. Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.
Cappellari M; Carletti M; Danese A; Bovi P
J Thromb Thrombolysis; 2016 Oct; 42(3):393-8. PubMed ID: 27329483
[TBL] [Abstract][Full Text] [Related]
10. Drug-Drug Interactions of FXI Inhibitors: Clinical Relevance.
Ferri N; Colombo E; Corsini A
Hematol Rep; 2024 Mar; 16(1):151-163. PubMed ID: 38534886
[TBL] [Abstract][Full Text] [Related]
11. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
12. Comprehension of Nonvalvular Atrial Fibrillation and Anticoagulant Adherence in Elderly Patients in a Subcohort Study of the All Nippon Atrial Fibrillation in the Elderly Registry.
Akao M; Yamashita T; Atarashi H; Ikeda T; Koretsune Y; Okumura K; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
Am J Cardiol; 2023 Oct; 204():159-167. PubMed ID: 37544138
[TBL] [Abstract][Full Text] [Related]
13. Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.
Zoppellaro G; Granziera S; Padayattil Jose S; Denas G; Bracco A; Iliceto S; Pengo V
Expert Opin Drug Saf; 2015 May; 14(5):683-95. PubMed ID: 25803739
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
Senoo K; Lip GY
Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
[TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study.
Anguita Sánchez M; Bertomeu Martínez V; Ruiz Ortiz M; Cequier Fillat Á; Roldán Rabadán I; Muñiz García J; Badimón Maestro L; Esteve Pastor MA; Marín Ortuño F;
Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):14-20. PubMed ID: 31160265
[TBL] [Abstract][Full Text] [Related]
16. Cardioembolic Stroke: Past Advancements, Current Challenges, and Future Directions.
Kato Y; Tsutsui K; Nakano S; Hayashi T; Suda S
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891965
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Management of Cardioembolic Stroke.
Yaghi S
Continuum (Minneap Minn); 2023 Apr; 29(2):462-485. PubMed ID: 37039405
[TBL] [Abstract][Full Text] [Related]
18. Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.
Blomström Lundqvist C; Själander S; Garcia Rodriguez LA; Åkerborg Ö; Jin G; Caleyachetty A; Huelsebeck M; Bowrin K; Schaefer B; Mahdessian H; Hofmeister L; Levin LÅ
J Med Econ; 2022; 25(1):1085-1091. PubMed ID: 35997241
[TBL] [Abstract][Full Text] [Related]
19. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of Hirudin plus Aspirin versus Warfarin in the secondary prevention of Cardioembolic Stroke due to Nonvalvular Atrial Fibrillation: A multicenter prospective cohort study.
Song CG; Bi LJ; Zhao JJ; Wang X; Li W; Yang F; Jiang W
Int J Med Sci; 2021; 18(5):1167-1178. PubMed ID: 33526977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
